Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Jan;11(1):1-11.
doi: 10.1111/j.1750-3639.2001.tb00376.x.

Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport

T A Bayer  1 , O Wirths, K Majtényi, T Hartmann, G Multhaup, K Beyreuther, C Czech
Affiliations
Review

Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport

T A Bayer et al. Brain Pathol. 2001 Jan.

Abstract

During the last years it has become evident that the beta-amyloid (Abeta) component of senile plaques may be the key molecule in the pathology of Alzheimer's disease (AD). The source and place of the neurotoxic action of Abeta, however, is still a matter of controversy. The precursor of the beta-amyloid peptide is the predominantly neuronal beta-amyloid precursor protein. We, and others, hypothesize that intraneuronal misregulation of APP leads to an accumulation of Abeta peptides in intracellular compartments. This accumulation impairs APP trafficking, which starts a cascade of pathological changes and causes the pyramidal neurons to degenerate. Enhanced Abeta secretion as a function of stressed neurons and remnants of degenerated neurons provide seeds for extracellular Abeta aggregates, which induce secondary degenerative events involving neighboring cells such as neurons, astroglia and macrophages/microglia. Beta-amyloid precursor protein has a pivotal role in Alzheimer's disease.

PubMed Disclaimer

References

    1. Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr Psych Gerichtl Med 64: 146–148.
    1. Bayer TA, Cappai R, Masters CL, Beyreuther K, Multhaup G (1999) It all sticks together—the APP‐related family of proteins and Alzheimer's disease. Mol Psychiatry 4: 524–528. - PubMed
    1. Bayer TA, Fossgreen A, Czech C, Beyreuther K, Wiestler OD (1996) Plaque formation in brain transplants exposed to human beta‐amyloid precursor protein 695. Acta Neuropathol (Berl) 92: 130–137. - PubMed
    1. Beyreuther K, Bush AI, Dyrks T, Hilbich C, Konig G, Monning U, Multhaup G, Prior R, Rumble B, Schubert W, et al. (1991) Mechanisms of amyloid deposition in Alzheimer's disease. Ann N Y Acad Sci 640: 129–139. - PubMed
    1. Borchardt T, Camakaris J, Cappai R, Masters CL, Beyreuther K, Multhaup G (1999) Copper inhibits beta‐amyloid production and stimulates the non‐ amyloidogenic pathway of amyloid‐precursor‐protein secretion. Biochem J 344: 461–467. - PMC - PubMed

Publication types